Introduction
During the last ten years, there have been a number of spectacular confrontations between government and private sector representatives of the North and the South 1 in the global health arena. The rapid spread of HIV/AIDS from a limited number of individuals in the industrialized nations to an ever-increasing number of people in the developing countries became the igniting spark for open conflict, pitting the national authorities of South Africa and Brazil against the transnational pharmaceutical companies (TNPCs, 'Big Pharma') and their governments. The results were remarkable, both with regard to the unexpected shifting power positions of the contestants as well as the implications for global health governance (GHG). The South succeeded in getting the prices of anti-retroviral drugs (ARVs) against AIDS significantly lowered so as to make 'treatment for all' an accepted norm in GHG. At the same time, the developing countries have also been able to strengthen the application of safeguards within the stringent patent right protection legislated under the Trade Related Intellectual Property Rights (TRIPS) agreement as part of the World Trade Organization (WTO) package that became international law in 1995.
This chapter will analyse the power and politics of the large researchoriented TNPCs, their accomplishments and current problems, and the increasing significance of the pharmaceutical industries in newly industrializing countries (NICs). It will focus on the two conflicts, their major causes as well as their resolution in the context of the multiple interactions of major actors in both rich and poor countries' health arena in general and its pharmaceutical markets in particular. It will address three issues proposed in the book's introduction concerning the role of 'Big Pharma', namely: (1) the major characteristics of TNPCs as actors in GHG and their changes over the last ten years; (2) the nature of their interfaces with the other actors in the context of the rapidly spreading HIV/AIDS crisis; and (3) the processes at these interfaces linked to the structure of and changes within national and global health governance.
After presenting a summary evaluation of the major characteristics of the TNPCs, a step-by-step analysis of the major interfaces the industry has had with public and private entities in the face of the HIV/AIDS crisis will form the heart of this chapter. The relationship between the interfaces and the emerging global health governance as well as the efforts of the business actors to come to terms with the new institutional structure are considered in the context of the latest developments of globalization and the TNPCs' particular efforts to move from a more defensive to an offensive strategy in tackling the access to medicines in developing countries.
The analysis will work with elements of strategy models, which have been used increasingly by economists, business analysts and legal experts. It will combine these approaches with a political science framework which examines the emergence of GHG in the context of multilevel governance outlined in Chapter 1. Particularly useful for analysing the TNPCs in the multiple public and private negotiations is a game theoryoriented approach and the notion of 'forum' or 'regime shifting' (Helfer 2004) , used by the corporations and the governments of the North in internationalizing intellectual property rights (IPRs) in the context of TRIPS. Not surprisingly, the international civil society organizations (CSOs) and representatives of the South reacted by using the same strategy in fighting for a 'Development Agenda' in the World Intellectual Property Organization (WIPO) and an increased public responsibility for 'Essential Health Research' in the World Health Organization (WHO).
Both groups of actors perceived their goals within a socio-political structure and an institutional setting which has allowed them to pursue these different objectives. In doing so, they have changed the very economic and social structure of the global health architecture, and with it the new concerns, activities and rules of GHG have emerged. At the same time, the emerging GHG is now shaping the perceptions and strategies of the very actors which have been so crucial in building it. In brief, the social interaction analysed here has been co-determined by the property of actors and the existing socio-political structure (Sell 2000) .
